» Articles » PMID: 25668519

Hepatocellular Carcinoma with β-Catenin Mutation: Imaging and Pathologic Characteristics

Abstract

Purpose: To identify the imaging features of hepatocellular carcinoma (HCC) associated with β-catenin mutation and their relationship to pathologic findings.

Materials And Methods: Institutional ethics committee approval and informed consent were obtained. One hundred thirty-eight surgically resected HCCs were analyzed in this study. Immunohistochemical expression of β-catenin and its transcriptional product, glutamine synthetase (GS), were graded and classified into three groups: the β-catenin positive and GS positive group (HCC with β-catenin mutation), the β-catenin negative and GS positive group (intermediate HCC), and the β-catenin negative and GS negative group (HCC without β-catenin mutation). Clinical, pathologic, and imaging findings from dynamic computed tomography (CT) and gadoxetic acid-enhanced magnetic resonance (MR) imaging (T1-weighted, T2-weighted, diffusion-weighted, and hepatobiliary phase imaging) were evaluated. Correlations among immunohistochemical expression of β-catenin, GS, and organic anion transporting polypeptide 1B3 (uptake transporter of gadoxetic acid) were evaluated. The χ(2), Kruskal-Wallis, and Spearman correlation tests were used.

Results: HCCs with β-catenin mutation (n = 27) showed a lower median contrast-to-noise ratio at diffusion-weighted imaging than did intermediate HCCs (n = 23) and HCCs without β-catenin mutation (n = 84) (13.2, 24.4, and 27.0, respectively; P = .02), higher apparent diffusion coefficient (1.33, 1.13, and 1.12, respectively; P < .0001), higher contrast-to-noise ratio (0.58, -28.7, and -45.0, respectively; P < .0001) and higher enhancement ratio during the hepatobiliary phase (0.90, 0.50, and 0.42, respectively; P < .0001). At pathologic examination, HCCs with β-catenin mutation showed pseudoglandular proliferation and bile production with a higher grade of differentiation (P = .04, .001, and .005, respectively). There were significant positive correlations among expression of β-catenin, GS, and organic anion transporting polypeptide 1B3 (P < .0001).

Conclusion: HCCs with β-catenin mutation showed a higher grade of differentiation with frequent pseudoglandular patterns and bile production, and characteristic imaging findings included a high enhancement ratio at gadoxetic acid-enhanced MR imaging and a high apparent diffusion coefficient at diffusion-weighted imaging. Online supplemental material is available for this article.

Citing Articles

Isolated Right Ventricular Metastasis of Hepatocellular Carcinoma: Clinical Findings and Histopathology of an Atypical Presentation.

See A, Kasiviswanathan P, Syed M, Minervini M, Sahin I, Krauze M JGH Open. 2024; 8(12):e70079.

PMID: 39713744 PMC: 11661002. DOI: 10.1002/jgh3.70079.


Exploring the Impact of the β-Catenin Mutations in Hepatocellular Carcinoma: An In-Depth Review.

Idrissi Y, Rajabi M, Beumer J, Monga S, Saeed A Cancer Control. 2024; 31:10732748241293680.

PMID: 39428608 PMC: 11528747. DOI: 10.1177/10732748241293680.


Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI.

Kunichika H, Minamiguchi K, Tachiiri T, Shimizu K, Taiji R, Yamada A Cancers (Basel). 2024; 16(12).

PMID: 38927979 PMC: 11202233. DOI: 10.3390/cancers16122275.


Quantitative radiomics and qualitative LI-RADS imaging descriptors for non-invasive assessment of β-catenin mutation status in hepatocellular carcinoma.

Arefan D, DArdenne N, Iranpour N, Catania R, Yousef J, Chupetlovska K Abdom Radiol (NY). 2024; 49(7):2220-2230.

PMID: 38782785 DOI: 10.1007/s00261-024-04344-2.


Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinoma.

Ziki R, Colnot S JHEP Rep. 2024; 6(5):101077.

PMID: 38699532 PMC: 11063524. DOI: 10.1016/j.jhepr.2024.101077.